Upon admission coagulation and platelet function in patients with thermal and electrical injuries

Autor: Wade, Charles E., Baer, Lisa A., Cardenas, Jessica C., Folkerson, Lindley E., Nutall-Aurora, Kisha, Cotton, Bryan A., Matijevic, Nena, Holcomb, John B., Cross, James M., Huzar, Todd

Publikováno v: In Burns December 2016 42(8):1704-1711

The Partition of the Punjab and of Bengal: Discussion

Autor: Brooks, Leonard, Stamp, L. Dudley, Fawcett, C. B., Lindley, E. S., East, W. G., Bajwa, Mushtaq Ahmad, Spate, O. H. K.

Publikováno v: The Geographical Journal, 1947 Oct 01. 110(4/6), 218-222.

Externí odkaz: https://www.jstor.org/stable/1789951

Upon admission coagulation and platelet function in patients with thermal and electrical injuries

Autor: Bryan A. Cotton, James M. Cross, Lisa A. Baer, Jessica C. Cardenas, Nena Matijevic, Charles E. Wade, Lindley E. Folkerson, Todd F Huzar, Kisha Nutall-Aurora, John B. Holcomb

Publikováno v: Burns. 42:1704-1711

Rational There has been increased focus on hemostatic potential and function in the initial assessment of the patient with traumatic injuries, that not been extensively studied in patients with burns. We proposed to determine the hemostatic potential

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59445b56340c816d5b03af96f25d161f
https://doi.org/10.1016/j.burns.2016.05.001

Coagulopathy as a predictor of mortality after penetrating traumatic brain injury

Autor: Jeffrey S. Tomasek, John B. Holcomb, Bryan A. Cotton, Duncan Sloan, Elizabeth Davis, Ryan S. Kitagawa, Lindley E. Folkerson, Charles E. Wade

Publikováno v: The American journal of emergency medicine. 36(1)

Traumatic brain injury (TBI) is a leading cause of mortality with penetrating TBI (p-TBI) patients having worse outcomes. These patients are more likely to be coagulopathic than blunt TBI (b-TBI) patients, thus we hypothesize that coagulopathy would

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::100fd95393dbc1e9cb060f26ec261b2f
https://pubmed.ncbi.nlm.nih.gov/28764996

Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement

Autor: Goldsmith, D., Covic, A., Vervloet, M., Cozzolino, M., Nistor, I., Brandenburg, V., Bover, J., Evenepoel, P., Massy, Z., Mazzaferro, S., Urena-Torres, P., Abramowicz, D., Bolignano, D., Cannata Andia, G., Cochat, P., Delvecchio, L., Drechsler, C., Eckardt, K. U., Fouque, D., Fox, J., Haller, M., Heimburger, O., Jager, K. J., Lindley, E., Marti Monros, A. M., Nagler, E., Oberbauer, R., Spasovski, G., Tattersall, J., Van Biesen, W., Vander Veer, S., Vanholder, R., Wanner, C., Wheeler, D., Whithers, W., Wiecek, A., Zoccali, C.

Publikováno v: Nephrology, dialysis, transplantation, 30(5), 698-700. Oxford University Press
Nephrology, Dialysis, Transplantation, 30(5), 698-700. Oxford University Press
Goldsmith, D, Covic, A, Vervloet, M G, Cozzolino, M & Nistor, I 2015, ' Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement ', Nephrology, Dialysis, Transplantation, vol. 30, no. 5, pp. 698-700 . https://doi.org/10.1093/ndt/gfv050

This paper reflects the position of the CKD-MBD workgroup, an official working group of ERA-EDTA and of the ERBP advisory board, the official guideline-producing body of ERA-EDTA, on the topic of the use of calcimimetics in patients with CKD stage 5D

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dac35206512de27167834fd7ec99ee1
https://doi.org/10.1093/ndt/gfv050